114
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats

, , , , , , , , & show all
Pages 1163-1173 | Published online: 01 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Jinran Li, Yuxi Jia, Peng Zhang, Huailin Yang, Xianling Cong, Lin An & Chunsheng Xiao. (2020) Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma. International Journal of Nanomedicine 15, pages 1205-1214.
Read now
Zhanrong Li, Zhihua Guo, Dandan Chu, Huayang Feng, Junjie Zhang, Lei Zhu & Jingguo Li. (2020) Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. Drug Delivery 27:1, pages 358-366.
Read now
Zhanrong Li, Jingguo Li, Lei Zhu, Ying Zhang, Junjie Zhang, Lin Yao, Dan Liang & Liya Wang. (2016) Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats. International Journal of Nanomedicine 11, pages 6135-6148.
Read now
Jingguo Li, Zhanrong Li, Tianyang Zhou, Junjie Zhang, Huiyun Xia, Heng Li, Jijun He, Siyu He & Liya Wang. (2015) Positively charged micelles based on a triblock copolymer demonstrate enhanced corneal penetration. International Journal of Nanomedicine 10, pages 6027-6037.
Read now
Xiaodan He, Li Li, Hong Su, Dinglun Zhou, Hongmei Song, Ling Wang & Xuehua Jiang. (2015) Poly(ethylene glycol)-block-poly(ε-caprolactone)–and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. International Journal of Nanomedicine 10, pages 1791-1804.
Read now
Zhanrong Li, Xianghua Wu, Jingguo Li, Lin Yao, Limei Sun, Yingying Shi, Wenxin Zhang, Jianxian Lin, Dan Liang & Yongping Li. (2012) Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model. International Journal of Nanomedicine 7, pages 2389-2398.
Read now

Articles from other publishers (9)

Paloma Carrillo, Melissa García-Caballero, Manuel Bernal, María Inmaculada Manrique-Poyato, Beatriz Martínez-Poveda, Ana R. Quesada & Miguel Ángel Medina. 2023. Matrix Pathobiology and Angiogenesis. Matrix Pathobiology and Angiogenesis 139 173 .
Qinyun Xia, Chujun Lyu, Fang Li, Binbin Pang, Xiaoyu Guo, He Ren, Yiqiao Xing & Zhen Chen. (2022) Candidate Drugs Screening for Behcet’s Disease Based on Bioinformatics Analysis and Mouse Experiments. Frontiers in Immunology 13.
Crossref
Anastasia Kyriakoudi, Eleni Spanidi, Ioannis Mourtzinos & Konstantinos Gardikis. (2021) Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications. Plants 10:6, pages 1238.
Crossref
Pushkaraj Rajendra Wagh, Preshita Desai, Sunil Prabhu & Jeffrey Wang. (2021) Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications. Frontiers in Pharmacology 12.
Crossref
Jinfeng Shi, Jiaxin Li, Ziyi Xu, Liang Chen, Ruifeng Luo, Chen Zhang, Fei Gao, Jinming Zhang & Chaomei Fu. (2020) Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application. Frontiers in Pharmacology 11.
Crossref
Lemei An, Zhanrong Li, Liuqi Shi, Liujun Wang, Yong Wang, Lin Jin, Xintao Shuai & Jingguo Li. (2020) Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways. Nano Letters 20:10, pages 7728-7736.
Crossref
Mengfei Guo, Ding Qu, Yue Qin, Yunyan Chen, Yuping Liu, Mengmeng Huang & Yan Chen. (2019) Transferrin-Functionalized Microemulsions Coloaded with Coix Seed Oil and Tripterine Deeply Penetrate To Improve Cervical Cancer Therapy. Molecular Pharmaceutics 16:12, pages 4826-4835.
Crossref
Shao-Ru Chen, Yan Dai, Jing Zhao, Ligen Lin, Yitao Wang & Ying Wang. (2018) A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F. Frontiers in Pharmacology 9.
Crossref
Rita Cascão, João E. Fonseca & Luis F. Moita. (2017) Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases. Frontiers in Medicine 4.
Crossref